Consumer Driven Health Care

A look at new legal battles and drug regulations, including the administration's new initiatives to reduce drug costs and next steps in the FTC's attempt to address improperly listed patents in the FDA's Orange Book.

With the price of GLP-1s reaching well over $1000 a month, local officials are warning that rising costs threaten to quickly drain government spending accounts.

The Value in Health Care Act would provide a 2-year extension of the 5% advanced payment model incentives, which allow clinicians to cover some of the costs of moving to a new payment model, including expanding care teams.

Alex Azar, former Health and Human Services secretary who approved of drug importation, is now chairman of the board of LifeScience Logistics, which is managing Florida's $39 million Canadian drug importation program.

The former South Carolina governor, who's now vying to be president, has become well known as one of the ACA's loudest critics, and is making her views known on abortion, vaccine mandates and other health care topics.

Value-based care, which focuses on quality of care and patient experience, kept patients healthier and lowered costs because they spent more time with their primary care doctors, according to Humana's 10th annual report.